Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray (Q58412739)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray	article

Statements

scholarly article

0 references

Prediction of Therapeutic Responses to Tocilizumab in Patients With Rheumatoid Arthritis: Biomarkers Identified by Analysis of Gene Expression in Peripheral Blood Mononuclear Cells Using Genome-Wide DNA Microarray (English)

0 references

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yoshie Sanayama

1

0 references

Kei Ikeda

2

0 references

Yukari Saito

3

0 references

Shin-ichiro Kagami

4

0 references

Mieko Yamagata

5

0 references

Shunsuke Furuta

6

0 references

Daisuke Kashiwakuma

7

0 references

Itsuo Iwamoto

8

0 references

Takeshi Umibe

9

0 references

Yasushi Nawata

10

0 references

Ryutaro Matsumura

11

0 references

Takao Sugiyama

12

0 references

Makoto Sueishi

13

0 references

Masaki Hiraguri

14

0 references

Ken Nonaka

15

0 references

Osamu Ohara

16

0 references

Hiroshi Nakajima

17

0 references

publication date

27 May 2014

0 references

Arthritis & Rheumatology

0 references

66

0 references

6

0 references

1421-1431

0 references

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

New therapies for treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

The pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells.

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Type I interferons (alpha/beta) in immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Autoimmune disease complicating antiviral therapy for hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Janus-like effects of type I interferon in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Immunopathogenic mechanisms of systemic autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

IL-17 and Th17 Cells

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

AT-Rich-Interactive Domain-Containing Protein 5A Functions as a Negative Regulator of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt-Induced Th17 Cell Differentiation

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Cross talk of the interferon-alpha/beta signalling complex with gp130 for effective interleukin-6 signalling

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Structural and functional analysis of the human metallothionein-IA gene: Differential induction by metal ions and glucocorticoids

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Metallothionein: the multipurpose protein

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Regulatory role of metallothionein in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept

1 reference

https://api.crossref.org/works/10.1002%2FART.38400

21 January 2018

Identifiers

10.1002/ART.38400

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58412739&oldid=1367014989"